Neonatal SSRI exposure programs a hypermetabolic state in adult mice

Journal of Nutrition and Metabolism

Volumn 2012, Issue , 2012, Pages

  Kummet, Gary J ^a   Haskell, Sarah E ^a   Hermann, Gregory M ^a   Ni, Charles ^a   Volk, Kenneth A ^a   Younes, Areej K ^a   Miller, Alise K ^a   Roghair, Robert D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUS; RODENTIA;

EID: 84873838444     PISSN: 20900724     EISSN: 20900732     Source Type: Journal    
DOI: 10.1155/2012/431574     Document Type: Article

References (54)

1. Gavin N. I., Gaynes B. N., Lohr K. N., Meltzer-Brody S., Gartlehner G., Swinson T., Perinatal depression: a systematic review of prevalence and incidence. Obstetrics & Gynecology 2005 106 5 1071 1083 2-s2.0-27444443499 (Pubitemid 41532916)
2. Cooper W. O., Willy M. E., Pont S. J., Ray W. A., Increasing use of antidepressants in pregnancy. American Journal of Obstetrics & Gynecology 2007 196 6 544.e1 544.e5 2-s2.0-34249752695 10.1016/j.ajog.2007.01.033 (Pubitemid 46836611)
3. ACOG Committee on Practice Bulletins-Obstetrics, Use of psychiatric medications during pregnancy and lactation. Obstetrics & Gynecology 2008 111 4 1001 1020 10.1097/AOG.0b013e31816fd910 (Pubitemid 351482644)
4. Bakker M. K., Kölling P., van den Berg P. B., de Walle H. E. K., de Jong van den Berg L. T. W., Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. British Journal of Clinical Pharmacology 2008 65 4 600 606 2-s2.0-40549137175 10.1111/j.1365-2125.2007.03048.x (Pubitemid 351365128)
5. Oberlander T. F., Warburton W., Misri S., Aghajanian J., Hertzman C., Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Archives of General Psychiatry 2006 63 8 898 906 2-s2.0-33746869251 10.1001/archpsyc.63.8.898 (Pubitemid 44188483)
6. Wichman C. L., Fothergill A., Moore K. M., Lang T. R., Heise R. H. Jr., Watson W. J., Recent trends in selective serotonin reuptake inhibitor use in pregnancy. Journal of Clinical Psychopharmacology 2008 28 6 714 716 2-s2.0-59049083592 10.1097/JCP.0b013e31818b53fd
7. Chambers C. D., Hernandez-Diaz S., van Marter L. J., Werler M. M., Louik C., Jones K. L., Mitchell A. A., Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. The New England Journal of Medicine 2006 354 6 579 587 2-s2.0-32144436098 10.1056/NEJMoa052744 (Pubitemid 43209105)
8. Croen L. A., lisa.a.croen@kp.org Grether J. K., Yoshida C. K., Odouli R., Hendrick V., Antidepressant use during pregnancy and childhood autism spectrum disorders. Archives of General Psychiatry 2011 68 11 1104 1112 10.1001/archgenpsychiatry.2011.73
9. Davidson S., Prokonov D., Taler M., Maayan R., Harell D., Gil-Ad I., Weizman A., Effect of exposure to selective serotonin reuptake inhibitors. In Utero on fetal growth: potential role for the IGF-I and HPA axes. Pediatric Research 2009 65 2 236 241 2-s2.0-60449107170 10.1203/PDR.0b013e318193594a
10. Kelly R. H., Russo J., Holt V. L., Danielsen B. H., Zatzick D. F., Walker E., Katon W., Psychiatric and substance use disorders as risk factors for low birth weight and preterm delivery. Obstetrics & Gynecology 2002 100 2 297 304 2-s2.0-0036340674 10.1016/S0029-7844(02)02014-8 (Pubitemid 34874793)
11. Levinson-Castiel R., Merlob P., Linder N., Sirota L., Klinger G., Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Archives of Pediatrics and Adolescent Medicine 2006 160 2 173 176 2-s2.0-32244441984 10.1001/archpedi.160.2.173 (Pubitemid 43213863)
12. Oberlander T. F., Gingrich J. A., Ansorge M. S., Sustained neurobehavioral effects of exposure to ssri antidepressants during development: molecular to clinical evidence. Clinical Pharmacology and Therapeutics 2009 86 6 672 677 2-s2.0-70450152340 10.1038/clpt.2009.201
13. Oberlander T. F., Grunau R., Mayes L., Riggs W., Rurak D., Papsdorf M., Misri S., Weinberg J., Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. Early Human Development 2008 84 10 689 697 2-s2.0-53249119013 10.1016/j.earlhumdev.2008.06.008
14. Romijn H. J., Hofman M. A., Gramsbergen A., At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby? Early Human Development 1991 26 1 61 67 2-s2.0-0025734533 10.1016/0378-3782(91)90044-4
15. Maciag D., Simpson K. L., Coppinger D., Lu Y., Wang Y., Lin R. C. S., Paul I. A., Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 2006 31 1 47 57 2-s2.0-32844459497 10.1038/sj.npp.1300823 (Pubitemid 43250940)
16. Darling R. D., rlin@umc.edu Alzghoul L., Zhang J., Khatri N., Paul I. A., Simpson K. L., Lin R. C.S., Perinatal citalopram exposure selectively increases locus ceruleus circuit function in male rats. Journal of Neuroscience 2011 31 46 16709 16715 10.1523/JNEUROSCI.3736-11.2011
17. Simpson K. L., Weaver K. J., de Villers-Sidani E., Lu J. Y.-F., Cai Z., Pang Y., Rodriguez-Porcel F., Paul I. A., Merzenich M., Lin R. C.S., rlin@umc.edu Perinatal antidepressant exposure alters cortical network function in rodents. Proceedings of the National Academy of Sciences of the United States of America 2011 108 45 18465 18470 10.1073/pnas.1109353108
18. Donner N., Handa R. J., Estrogen receptor beta regulates the expression of tryptophan-hydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience 2009 163 2 705 718 2-s2.0-69249214037 10.1016/j.neuroscience.2009.06.046
19. Shinozaki T., Kimura M., Hosoyamada M., Shibasaki T., Fluvoxamine inhibits weight gain and food intake in food restricted hyperphagic wistar rats. Biological and Pharmaceutical Bulletin 2008 31 12 2250 2254 2-s2.0-57349133071 10.1248/bpb.31.2250
20. Scalco A. Z., Rondon M. U. P. B., Trombetta I. C., Laterza M. C., Azul J. B., Pullenayegum E. M., Scalco M. Z., Kuniyoshi F. H., Wajngarten M., Negréo C. E., Lotufo-Neto F., Muscle sympathetic nervous activity in depressed patients before and after treatment with sertraline. Journal of Hypertension 2009 27 12 2429 2436 2-s2.0-73649086262 10.1097/HJH. 0b013e3283310ece
21. Shores M. M., Pascualy M., Lewis N. L., Flatness D., Veith R. C., Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects. Psychoneuroendocrinology 2001 26 4 433 439 2-s2.0-0035107201 10.1016/S0306-4530(01)00002-6 (Pubitemid 32222947)
22. Erkonen G. E., Hermann G. M., Miller R. L., Thedens D. L., Nopoulos P. C., Wemmie J. A., Roghair R. D., robert-roghair@uiowa.edu Neonatal leptin administration alters regional brain volumes and blocks neonatal growth restriction-induced behavioral and cardiovascular dysfunction in male mice. Pediatric Research 2011 69 5 406 412 10.1203/PDR.0b013e3182110c7d
23. Matthews P. A., Samuelsson A.-M., Seed P., Pombo J., Oben J. A., Poston L., Taylor P. D., paul.taylor@kcl.ac.uk Fostering in mice induces cardiovascular and metabolic dysfunction in adulthood. Journal of Physiology 2011 589 16 3969 3981 10.1113/jphysiol.2011.212324
24. Cheung M. C., Spalding P. B., Gutierrez J. C., Balkan W., Namias N., Koniaris L. G., Zimmers T. A., Body surface area prediction in normal, hypermuscular, and obese mice. Journal of Surgical Research 2009 153 2 326 331 2-s2.0-64849109000 10.1016/j.jss.2008.05.002
25. Du Bois D., Du Bois E. F., A formula to estimate the approximate surface area if height and weight be known. Archives of Internal Medicine 1916 17 863 871
26. Hendrick V., Stowe Z. N., Altshuler L. L., Hwang S., Lee E., Haynes D., Placental passage of antidepressant medications. The American Journal of Psychiatry 2003 160 5 993 996 2-s2.0-0038521163 10.1176/appi.ajp.160.5.993 (Pubitemid 41079587)
27. Hermann G. M., Miller R. L., Erkonen G. E., Dallas L. M., Hsu E., Zhu V., Roghair R. D., Neonatal catch up growth increases diabetes susceptibility but improves behavioral and cardiovascular outcomes of low birth weight male mice. Pediatric Research 2009 66 1 53 58 2-s2.0-70149109440 10.1203/PDR. 0b013e3181a7c5fd
28. Freeman M. P., Nolan P. E. Jr., Davis M. F., Anthony M., Fried K., Fankhauser M., Woosley R. L., Moreno F., Pharmacokinetics of sertraline across pregnancy and postpartum. Journal of Clinical Psychopharmacology 2008 28 6 646 653 2-s2.0-59049095200 10.1097/JCP.0b013e31818d2048
29. Reis M., Aamo T., Spigset O., Ahlner J., Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database. Therapeutic Drug Monitoring 2009 31 1 42 56 2-s2.0-60449119332 10.1097/FTD.0b013e31819114ea
30. Skene D. J., Timbers S. E., Middleton B., English J., Kopp C., Tobler I., Ioannides C., Mice convert melatonin to 6-sulphatoxymelatonin. General and Comparative Endocrinology 2006 147 3 371 376 2-s2.0-33646822139 10.1016/j.ygcen.2006.02.009 (Pubitemid 43767252)
31. Kornum J. B., Nielsen R. B., Pedersen L., Mortensen P. B., Nørgaard M., Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis. Clinical Epidemiology 2010 2 1 29 36 2-s2.0-77953391067
32. Louik C., Lin A. E., Werler M. M., Hernández-Díaz S., Mitchell A. A., First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. The New England Journal of Medicine 2007 356 26 2675 2683 2-s2.0-34347255039 10.1056/NEJMoa067407 (Pubitemid 47001035)
33. Noorlander C. W., Ververs F. F. T., Nikkels P. G. J., van Echteld C. J. A., Visser G. H. A., Smidt M. P., Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities. PLoS ONE 2008 3 7 2-s2.0-49949099705 10.1371/journal.pone.0002782 e2782
34. Pedersen L. H., Henriksen T. B., Vestergaard M., Olsen J., Bech B. H., Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. British Medical Journal 2009 339 b3569 2-s2.0-70349432273 10.1136/bmj.b3569
35. Deiró T. C. B. J., Manhães-de-Castro R., Cabral-Filho J. E., Barreto-Medeiros J. M., Souza S. L., Marinho S. M. O. C., Castro F. M. M., Toscano A. E., Jesus-Deiró R. A., Barros K. M. F. T., Sertraline delays the somatic growth and reflex ontogeny in neonate rats. Physiology and Behavior 2006 87 2 338 344 2-s2.0-31944450347 10.1016/j.physbeh.2005.10.003 (Pubitemid 43188830)
36. Tremaine L. M., Welch W. M., Ronfeld R. A., Metabolism and disposition of the 5-hydroxytryptamine uptake blocker sertraline in the rat and dog. Drug Metabolism and Disposition 1989 17 5 542 550 2-s2.0-0024386144 (Pubitemid 19244919)
37. Ronfeld R. A., Tremaine L. M., Wilner K. D., Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers. Clinical Pharmacokinetics 1997 32, supplement 1 22 30 2-s2.0-0031017313 (Pubitemid 27107716)
38. Klinger G., gilkl@post.tau.ac.il Frankenthal D., Merlob P., Diamond G., Sirota L., Levinson-Castiel R., Linder N., Stahl B., Inbar D., Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. Journal of Perinatology 2011 31 9 615 620 10.1038/jp.2010.211
39. Anelli M., Bizzi A., Caccia S., Codegoni A. M., Fracasso C., Garattini S., Anorectic activity of fluoxetine and norfluoxetine in mice, rats and guinea-pigs. Journal of Pharmacy and Pharmacology 1992 44 8 696 698 2-s2.0-0026783028
40. Dryden S., Frankish H. M., Wang Q., Pickavance L., Williams G., The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats. Neuroscience 1996 72 2 557 566 2-s2.0-0029985448 10.1016/0306-4522(95)00566-8 (Pubitemid 26111212)
41. Gluckman P. D., Hanson M. A., Cooper C., Thornburg K. L., Effect of in utero and early-life conditions on adult health and disease. The New England Journal of Medicine 2008 359 1 6 73 2-s2.0-46449087037 10.1056/NEJMra0708473 (Pubitemid 351931097)
42. Zill P., Büttner A., Eisenmenger W., Möller H. J., Ackenheil M., Bondy B., Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study. Journal of Psychiatric Research 2007 41 1-2 168 173 2-s2.0-33750725388 10.1016/j.jpsychires.2005.05.004 (Pubitemid 44708201)
43. Perroud N., Neidhart E., Petit B., Vessaz M., Laforge T., Relecom C., La Harpe R., Malafosse A., Guipponi M., Simultaneous analysis of serotonin transporter, tryptophan hydroxylase 1 and 2 gene expression in the ventral prefrontal cortex of suicide victims. American Journal of Medical Genetics B 2010 153 4 909 918 2-s2.0-77952690277 10.1002/ajmg.b.31059
44. Singh V. B., Corley K. C., Phan T. H., Boadle-Biber M. C., Increases in the activity of tryptophan hydroxylase from rat cortex and midbrain in response to acute or repeated sound stress are blocked by adrenalectomy and restored by dexamethasone treatment. Brain Research 1990 516 1 66 76 2-s2.0-0025352994 10.1016/0006-8993(90)90898-L (Pubitemid 20189201)
45. Kim S. W., Park S. Y., Hwang O., Up-regulation of tryptophan hydroxylase expression and serotonin synthesis by sertraline. Molecular Pharmacology 2002 61 4 778 785 2-s2.0-0036205443 10.1124/mol.61.4.778 (Pubitemid 34273157)
46. Sakowski S. A., Geddes T. J., Thomas D. M., Levi E., Hatfield J. S., Kuhn D. M., Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies. Brain Research 2006 1085 1 11 18 2-s2.0-33646542677 10.1016/j.brainres.2006.02.047 (Pubitemid 43728204)
47. Abumaria N., Rygula R., Hiemke C., Fuchs E., Havemann-Reinecke U., Rüther E., Flügge G., Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the rat. European Neuropsychopharmacology 2007 17 6-7 417 429 2-s2.0-33947679272 10.1016/j.euroneuro.2006.08.009 (Pubitemid 46497654)
48. Hintz S. R., Kendrick D. E., Vohr B. R., Poole W. K., Higgins R. D., Gender differences in neurodevelopmental outcomes among extremely preterm, extremely-low-birthweight infants. Acta Paediatrica 2006 95 10 1239 1248 2-s2.0-33748854798 10.1080/08035250600599727 (Pubitemid 44423190)
49. Zambrano E., Bautista C. J., Deás M., Martínez-Samayoa P. M., González-Zamorano M., Ledesma H., Morales J., Larrea F., Nathanielsz P. W., A low maternal protein diet during pregnancy and lactation has sex- and window of exposure-specific effects on offspring growth and food intake, glucose metabolism and serum leptin in the rat. Journal of Physiology 2006 571 1 221 230 2-s2.0-33645282282 10.1113/jphysiol.2005.100313
50. Ojeda N. B., Intapad S., Royals T. P., Black J. T., Dasinger J. H., Tull F. L., Alexander B. T., balexander@umc.edu Hypersensitivity to acute ANG II in female growth-restricted offspring is exacerbated by ovariectomy. American Journal of Physiology 2011 301 4 R1199 R1205 10.1152/ajpregu.00219.2011
51. Nakamura K., Sugawara Y., Sawabe K., Ohashi A., Tsurui H., Xiu Y., Ohtsuji M., Qing S. L., Nishimura H., Hasegawa H., Hirose S., Late developmental stage-specific role of tryptophan hydroxylase 1 in brain serotonin levels. Journal of Neuroscience 2006 26 2 530 534 2-s2.0-32544455435 10.1523/JNEUROSCI.1835-05.2006 (Pubitemid 43237117)
52. de Pedro N., Martínez-Álvarez R. M., Delgado M. J., Melatonin reduces body weight in goldfish (Carassius auratus): effects on metabolic resources and some feeding regulators. Journal of Pineal Research 2008 45 1 32 39 2-s2.0-47249136476 10.1111/j.1600-079X.2007.00553.x (Pubitemid 351986260)
53. Prunet-Marcassus B., Desbazeille M., Bros A., Louche K., Delagrange P., Renard P., Casteilla L., Pénicaud L., Melatonin reduces body weight gain in sprague dawley rats with diet-induced obesity. Endocrinology 2003 144 12 5347 5352 2-s2.0-0344825820 10.1210/en.2003-0693 (Pubitemid 37476063)
54. Reyes-Toso C. F., Rebagliati I. R., Ricci C. R., Linares L. M., Albornoz L. E., Cardinali D. P., Zaninovich A., Effect of melatonin treatment on oxygen consumption by rat liver mitochondria. Amino Acids 2006 31 3 299 302 2-s2.0-33749552135 10.1007/s00726-005-0280-z (Pubitemid 44537055)